Home > Income Statement > INDOCO REMEDIES

INDOCO REMEDIES
Consolidated Net Profit

    Back to Income Statement
INDOCO REMEDIES is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for INDOCO REMEDIES
Please provide your vote to see the results

INDOCO REMEDIES Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Consolidated Net Profit ₹-74 Cr₹98 Cr₹142 Cr₹155 Cr₹93 Cr

What is the latest Consolidated Net Profit of INDOCO REMEDIES ?

The latest Consolidated Net Profit ratio of INDOCO REMEDIES is ₹-74 Cr based on Mar2025 Consolidated results.
Year Consolidated Net Profit
Mar2025₹-74 Cr
Mar2024₹98 Cr
Mar2023₹142 Cr
Mar2022₹155 Cr
Mar2021₹93 Cr

How is Consolidated Net Profit of INDOCO REMEDIES Trending?

Years Consolidated Net Profit % Change
Mar2025 ₹-74 Cr
Negative
Mar2024 ₹98 Cr
-30.78
Mar2023 ₹142 Cr
-8.11
Mar2022 ₹155 Cr
66.37
Mar2021 ₹93 Cr -

Compare Consolidated Net Profit of peers of INDOCO REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
INDOCO REMEDIES ₹2,208.7 Cr 16.4% 5.8% -14.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹433,428.0 Cr 1.5% -3% 6.7% Stock Analytics
DIVIS LABORATORIES ₹175,426.0 Cr -2.2% -4.5% 0.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹152,603.0 Cr 0.8% 2.3% 43.9% Stock Analytics
CIPLA ₹111,604.0 Cr 0.4% -4% -7.8% Stock Analytics
DR REDDYS LABORATORIES ₹106,775.0 Cr 0.8% -1.8% -3.4% Stock Analytics


INDOCO REMEDIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
INDOCO REMEDIES

16.4%

5.8%

-14.6%

SENSEX

3.7%

2.2%

-7.2%


You may also like the below Video Courses